Insight

Sumanta K. Pal: Terrific AUC3 debate between Michiel van der Heijden and Roger Li on NMIBC management

Sumanta K. Pal/X

Jan 26, 2025, 08:41

Sumanta K. Pal: Terrific AUC3 debate between Michiel van der Heijden and Roger Li on NMIBC management

Sumanta K. Pal, Medical Oncologist at City of Hope, posted the following on X:

“Terrific AUC3 debate between Michiel van der Heijden and Roger Li on NMIBC management (local v systemic). As both concede, data for emerging local therapies very compelling, but possibly (possibly) a role for local + systemic.

Great paper from Roger in Nature Medicine that supports this approach.”

sumanta k. pal

Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial

Authors: Roger Li et al.

Sumanta K. Pal: Terrific AUC3 debate between Michiel van der Heijden and Roger Li on NMIBC management

Alexander R. A. Anderson Carlos M Moran Segura Colin P.N. Dinney Denise Dorman G. Daniel Grass Gustavo Borjas James J. Mulé James M. Burke Jasreman Dhillon Jingsong Zhang John J. Powers Jose R. Conejo-Garcia Joseph O. Johnson Julio M. Pow-Sang Logan Zemp Michael A. Poch Michiel van der Heijden Nancy Y. Villa Natasha Francis Paulo C. Rodriguez Philippe E. Spiess Roger Li Rohit K. Jain Scott M. Gilbert Tingyi Li Wade J. Sexton Xiaoqing Yu Xuefeng Wang Youngchul Kim

Hagop Kantarjian: Advances and Revolution in Adult ALL Therapy Over the Last Decade

FDA Priority Review Granted for TAR-200 After 82% Complete Response in BCG-Unresponsive Bladder Cancer

Top 10 Immunotherapy Fellowships and Grants to Watch in 2025

July Is Sarcoma Awareness Month: What You Need to Know

Pat Soon-Shiong: SARS-CoV-2 Infection Can Awaken Sleeping Cancer Cells